Study of the Effects of Probiotics Upon Infectious Episodes in Subject Aged More Than 60, During Winter.
Not Applicable
Completed
- Conditions
- Infectious Episodes (ENT, Gastro-intestinal and Pulmonary)
- Registration Number
- NCT00796393
- Lead Sponsor
- Institut Rosell Lallemand
- Brief Summary
We put forward that probiotics have an effect on infectious episodes evolution in subjects aged 60 years or over. The main objective of this research is to observe the effect of consumption of the probiotic on the average number of days with infectious episodes.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
- Subjects who accept not to alter their food habits
Exclusion Criteria
- Food allergy
- Regular consumption of probiotics
- Diabetes
- Respiratory deficiency
- Cardiac deficiency
- Cancer or chronicle disease not stabilized
- Splenectomy, sickle-cell anemia
- Immuno depression or immunodeficiency acquired or congenital
- Immuno depressor or corticoid treatments
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Number of infectious episodes During the study
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the probiotic effects on ENT and pulmonary infections in elderly patients as studied in NCT00796393?
How does the probiotic intervention in NCT00796393 compare to standard-of-care treatments for winter-related infectious episodes in geriatric populations?
Are there specific biomarkers that predict response to probiotic therapy in reducing infectious episodes in elderly subjects during winter?
What are the potential adverse events associated with long-term probiotic consumption in NCT00796393 and how were they managed?
What related compounds or combination therapies have been explored for preventing gastrointestinal and respiratory infections in elderly populations similar to NCT00796393?
Trial Locations
- Locations (1)
Biofortis
🇫🇷Nantes, France
Biofortis🇫🇷Nantes, France